Cargando…

Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer

PURPOSE: Tumor-associated macrophages (TAMs) are activated macrophages associated with tumor progression in various cancers. TAMs can polarize M1 or M2 type. M1 has a pro-inflammatory function and kills pathogens. Conversely, M2 shows immunosuppressive action and promotes tumor growth. There are var...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hasong, Hwang, Ilseon, Kang, Sun Hee, Shin, Hyeong Chan, Kwon, Sun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438840/
https://www.ncbi.nlm.nih.gov/pubmed/30941232
http://dx.doi.org/10.4048/jbc.2019.22.e5
_version_ 1783407155407224832
author Jeong, Hasong
Hwang, Ilseon
Kang, Sun Hee
Shin, Hyeong Chan
Kwon, Sun Young
author_facet Jeong, Hasong
Hwang, Ilseon
Kang, Sun Hee
Shin, Hyeong Chan
Kwon, Sun Young
author_sort Jeong, Hasong
collection PubMed
description PURPOSE: Tumor-associated macrophages (TAMs) are activated macrophages associated with tumor progression in various cancers. TAMs can polarize M1 or M2 type. M1 has a pro-inflammatory function and kills pathogens. Conversely, M2 shows immunosuppressive action and promotes tumor growth. There are various markers of TAMs. CD11c is considered as a specific marker of M1. CD163 is an optimal marker for M2. CD68 is known as a pan-macrophage marker. We evaluated the relationship between the clinicopathological parameters and immunohistochemical expressions of CD11c, CD163, and CD68 in invasive breast cancer (IBC), and the prognostic value of macrophage localization within the tumor stroma (TS) and tumor nest (TN). METHODS: Immunohistochemistry of CD68, CD11c, and CD163 was analyzed on tissue microarrays of 367 IBCs. The number of CD68+, CD11c+, or CD163+ macrophages in TN vs. TS was counted by 2 pathologists. The correlations between the degree of macrophage (CD68+, CD11c+, or CD163+) infiltration and the clinicopathological parameters were analyzed. We also assessed the impact of macrophages (CD68+, CD11c+, or CD163+) on disease free survival (DFS) and overall survival (OS). RESULTS: High numbers of macrophages (CD68+, CD11c+, or CD163+) were associated with higher histologic grade, higher Ki-67 proliferating index, estrogen receptor negativity, and progesterone receptor negativity. High numbers of macrophages (CD11c+ or CD163+) in TS were associated with a larger tumor size. Furthermore, CD163+ macrophages in TN were an independent prognostic marker of reduced OS and DFS. Conversely, CD11c+ macrophages in TS were an independent prognostic marker for higher OS and DFS. CONCLUSION: TAMs, including M2 type, are associated with tumor progression in IBC. They can also act as a significant unfavorable or favorable prognostic factor. In addition to simply analyzing the degree of TAM infiltration, it is also important to analyze the location of TAMs.
format Online
Article
Text
id pubmed-6438840
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Breast Cancer Society
record_format MEDLINE/PubMed
spelling pubmed-64388402019-04-02 Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer Jeong, Hasong Hwang, Ilseon Kang, Sun Hee Shin, Hyeong Chan Kwon, Sun Young J Breast Cancer Original Article PURPOSE: Tumor-associated macrophages (TAMs) are activated macrophages associated with tumor progression in various cancers. TAMs can polarize M1 or M2 type. M1 has a pro-inflammatory function and kills pathogens. Conversely, M2 shows immunosuppressive action and promotes tumor growth. There are various markers of TAMs. CD11c is considered as a specific marker of M1. CD163 is an optimal marker for M2. CD68 is known as a pan-macrophage marker. We evaluated the relationship between the clinicopathological parameters and immunohistochemical expressions of CD11c, CD163, and CD68 in invasive breast cancer (IBC), and the prognostic value of macrophage localization within the tumor stroma (TS) and tumor nest (TN). METHODS: Immunohistochemistry of CD68, CD11c, and CD163 was analyzed on tissue microarrays of 367 IBCs. The number of CD68+, CD11c+, or CD163+ macrophages in TN vs. TS was counted by 2 pathologists. The correlations between the degree of macrophage (CD68+, CD11c+, or CD163+) infiltration and the clinicopathological parameters were analyzed. We also assessed the impact of macrophages (CD68+, CD11c+, or CD163+) on disease free survival (DFS) and overall survival (OS). RESULTS: High numbers of macrophages (CD68+, CD11c+, or CD163+) were associated with higher histologic grade, higher Ki-67 proliferating index, estrogen receptor negativity, and progesterone receptor negativity. High numbers of macrophages (CD11c+ or CD163+) in TS were associated with a larger tumor size. Furthermore, CD163+ macrophages in TN were an independent prognostic marker of reduced OS and DFS. Conversely, CD11c+ macrophages in TS were an independent prognostic marker for higher OS and DFS. CONCLUSION: TAMs, including M2 type, are associated with tumor progression in IBC. They can also act as a significant unfavorable or favorable prognostic factor. In addition to simply analyzing the degree of TAM infiltration, it is also important to analyze the location of TAMs. Korean Breast Cancer Society 2019-01-02 /pmc/articles/PMC6438840/ /pubmed/30941232 http://dx.doi.org/10.4048/jbc.2019.22.e5 Text en © 2019 Korean Breast Cancer Society https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jeong, Hasong
Hwang, Ilseon
Kang, Sun Hee
Shin, Hyeong Chan
Kwon, Sun Young
Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
title Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
title_full Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
title_fullStr Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
title_full_unstemmed Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
title_short Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
title_sort tumor-associated macrophages as potential prognostic biomarkers of invasive breast cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438840/
https://www.ncbi.nlm.nih.gov/pubmed/30941232
http://dx.doi.org/10.4048/jbc.2019.22.e5
work_keys_str_mv AT jeonghasong tumorassociatedmacrophagesaspotentialprognosticbiomarkersofinvasivebreastcancer
AT hwangilseon tumorassociatedmacrophagesaspotentialprognosticbiomarkersofinvasivebreastcancer
AT kangsunhee tumorassociatedmacrophagesaspotentialprognosticbiomarkersofinvasivebreastcancer
AT shinhyeongchan tumorassociatedmacrophagesaspotentialprognosticbiomarkersofinvasivebreastcancer
AT kwonsunyoung tumorassociatedmacrophagesaspotentialprognosticbiomarkersofinvasivebreastcancer